192 related articles for article (PubMed ID: 11850532)
1. Tissue distribution and induction of human multidrug resistant protein 3.
Scheffer GL; Kool M; de Haas M; de Vree JM; Pijnenborg AC; Bosman DK; Elferink RP; van der Valk P; Borst P; Scheper RJ
Lab Invest; 2002 Feb; 82(2):193-201. PubMed ID: 11850532
[TBL] [Abstract][Full Text] [Related]
2. Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver.
Soroka CJ; Lee JM; Azzaroli F; Boyer JL
Hepatology; 2001 Apr; 33(4):783-91. PubMed ID: 11283840
[TBL] [Abstract][Full Text] [Related]
3. Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway.
Chai J; He Y; Cai SY; Jiang Z; Wang H; Li Q; Chen L; Peng Z; He X; Wu X; Xiao T; Wang R; Boyer JL; Chen W
Hepatology; 2012 May; 55(5):1485-94. PubMed ID: 22105759
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver.
Donner MG; Keppler D
Hepatology; 2001 Aug; 34(2):351-9. PubMed ID: 11481620
[TBL] [Abstract][Full Text] [Related]
5. Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia.
Rost D; König J; Weiss G; Klar E; Stremmel W; Keppler D
Gastroenterology; 2001 Nov; 121(5):1203-8. PubMed ID: 11677213
[TBL] [Abstract][Full Text] [Related]
6. Induction of hepatic multidrug resistance-associated protein 3 by ethynylestradiol is independent of cholestasis and mediated by estrogen receptor.
Ruiz ML; Rigalli JP; Arias A; Villanueva S; Banchio C; Vore M; Mottino AD; Catania VA
Drug Metab Dispos; 2013 Feb; 41(2):275-80. PubMed ID: 23077105
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane.
König J; Rost D; Cui Y; Keppler D
Hepatology; 1999 Apr; 29(4):1156-63. PubMed ID: 10094960
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels.
Young LC; Campling BG; Cole SP; Deeley RG; Gerlach JH
Clin Cancer Res; 2001 Jun; 7(6):1798-804. PubMed ID: 11410522
[TBL] [Abstract][Full Text] [Related]
9. Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma.
Nies AT; König J; Pfannschmidt M; Klar E; Hofmann WJ; Keppler D
Int J Cancer; 2001 Nov; 94(4):492-9. PubMed ID: 11745434
[TBL] [Abstract][Full Text] [Related]
10. Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas.
Rau S; Autschbach F; Riedel HD; Konig J; Kulaksiz H; Stiehl A; Riemann JF; Rost D
Eur J Clin Invest; 2008 Feb; 38(2):134-42. PubMed ID: 18226047
[TBL] [Abstract][Full Text] [Related]
11. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
Shoda J; Kano M; Oda K; Kamiya J; Nimura Y; Suzuki H; Sugiyama Y; Miyazaki H; Todoroki T; Stengelin S; Kramer W; Matsuzaki Y; Tanaka N
Am J Gastroenterol; 2001 Dec; 96(12):3368-78. PubMed ID: 11774951
[TBL] [Abstract][Full Text] [Related]
12. Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats.
Kuroda M; Kobayashi Y; Tanaka Y; Itani T; Mifuji R; Araki J; Kaito M; Adachi Y
J Gastroenterol Hepatol; 2004 Feb; 19(2):146-53. PubMed ID: 14731123
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis.
Bohan A; Chen WS; Denson LA; Held MA; Boyer JL
J Biol Chem; 2003 Sep; 278(38):36688-98. PubMed ID: 12837754
[TBL] [Abstract][Full Text] [Related]
14. The Function of Multidrug Resistance-associated Protein 3 in the Transport of Bile Acids under Normal Physiological and Lithocholic Acid-induced Cholestasis Conditions.
Wang W; Zeng S; Hu M; Liu Z; Gong L
Curr Drug Metab; 2021; 22(5):353-362. PubMed ID: 33461458
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Assessment of the Expression of Biliary Transportation Proteins MRP2 and MRP3 in Hepatocellular Carcinoma and in Cholangiocarcinoma.
Cirqueira CS; Felipe-Silva AS; Wakamatsu A; Marins LV; Rocha EC; de Mello ES; Alves VAF
Pathol Oncol Res; 2019 Oct; 25(4):1363-1371. PubMed ID: 29464551
[TBL] [Abstract][Full Text] [Related]
16. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease.
Ros JE; Libbrecht L; Geuken M; Jansen PL; Roskams TA
J Pathol; 2003 Aug; 200(5):553-60. PubMed ID: 12898590
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the in vivo functions of Mrp3.
Belinsky MG; Dawson PA; Shchaveleva I; Bain LJ; Wang R; Ling V; Chen ZS; Grinberg A; Westphal H; Klein-Szanto A; Lerro A; Kruh GD
Mol Pharmacol; 2005 Jul; 68(1):160-8. PubMed ID: 15814571
[TBL] [Abstract][Full Text] [Related]
18. Alteration of the expression of adenosine triphosphate-binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis.
Kamisako T; Ogawa H
J Gastroenterol Hepatol; 2005 Sep; 20(9):1429-34. PubMed ID: 16105132
[TBL] [Abstract][Full Text] [Related]
19. The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia.
Keppler D
Drug Metab Dispos; 2014 Apr; 42(4):561-5. PubMed ID: 24459177
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS.
Donner MG; Warskulat U; Saha N; Häussinger D
Biol Chem; 2004; 385(3-4):331-9. PubMed ID: 15134348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
